Edition:
India

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

92.23USD
2 Jul 2020
Change (% chg)

$0.59 (+0.64%)
Prev Close
$91.64
Open
$92.38
Day's High
$93.05
Day's Low
$91.95
Volume
1,166,535
Avg. Vol
2,385,798
52-wk High
$99.99
52-wk Low
$61.62

Summary

Name Age Since Current Position

Miles White

65 2020 Executive Chairman of the Board

Robert Ford

46 2020 President, Chief Executive Officer, Chief Operating Officer, Director

Robert Funck

58 2020 Chief Financial Officer, Executive Vice President - Finance

Hubert Allen

54 2013 Executive Vice President, General Counsel, Secretary

Mary Moreland

53 2019 Executive Vice President of Human Resources

John Capek

58 2015 Executive Vice President - Ventures

Lisa Earnhardt

50 2019 Executive Vice President - Medical Devices

John Ginascol

61 2019 Executive Vice President - Core Diagnostics

Andrew Lane

49 2017 Executive Vice President - Established Pharmaceuticals

Daniel Salvadori

41 2017 Executive Vice President - Nutritional Products

Andrea Wainer

51 2019 Executive Vice President - Rapid and Molecular Diagnostics

Roger Bird

63 2015 Senior Vice President - U.S. Nutrition

Charles Brynelsen

63 2017 Senior Vice President - Abbott Vascular

Jaime Contreras

63 2013 Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Michael Dale

60 2019 Senior Vice President - Structural Heart

Sammy Karam

58 2019 Senior Vice President - Established Pharmaceuticals, Emerging Markets

Joseph Manning

51 2017 Senior Vice President - Nutrition International

Michael Pederson

58 2019 Senior Vice President - Electrophysiology and Heart Failure

Christopher Scoggins

50 2019 Senior Vice President - Rapid Diagnostics

Jared Watkin

52 2015 Senior Vice President - Diabetes Care

Alejandro Wellisch

45 2017 Senior Vice President - Established Pharmaceuticals, Latin America

Randel Woodgrift

58 2019 Senior Vice President - CRM

William Osborn

72 2013 Lead Independent Director

Robert Alpern

69 2008 Independent Director

Roxanne Austin

59 2000 Independent Director

Sally Blount

58 2011 Independent Director

Michelle Kumbier

52 2018 Independent Director

Edward Liddy

73 2010 Independent Director

Darren McDew

59 2019 Independent Director

Nancy McKinstry

61 2011 Independent Director

Phebe Novakovic

62 2010 Independent Director

Samuel Scott

75 2007 Independent Director

Daniel Starks

65 2017 Independent Director

John Stratton

59 2017 Independent Director

Glenn Tilton

71 2007 Independent Director

Biographies

Name Description

Miles White

Mr. Miles D. White has been appointed as Executive Chairman of the Board of the Company. Mr. White has served as Abbott's Chairman of the Board and Chief Executive Officer since 1999. He served as an Executive Vice President of Abbott from 1998 to 1999. He joined Abbott in 1984. He currently serves as a Director of Caterpillar Inc. and McDonald's Corporation. Serving as Abbott's Chairman of the Board and Chief Executive Officer since 1999 and having joined Abbott in 1984, Mr. White contributes not only his valuable business, management and leadership experience, but also his extensive knowledge of the Company and its global operations, as well as key insights into strategic, management and operation matters, ensuring the appropriate level of oversight and responsibility is applied to all Board decisions.

Robert Ford

Mr. Robert B. Ford has been appointed as President, Chief Executive Officer, Chief Operating Officer, Director of the Company effective 3/31/2020. He served as Senior Vice President, Diabetes Care of the Company between 2014 and 2015. From 2008 to 2014 — Vice President, Diabetes Care, Commercial Operations. He was elected Corporate Officer — 2008.

Robert Funck

Mr. Robert E. Funck serves as Chief Financial Officer, Executive Vice President - Finance of the Company. Mr. Funck has served as Abbott’s Senior Vice President, Finance and Controller since 2018 and served as Vice President, Controller from 2013 to 2018, as Vice President, Chief Ethics and Compliance Officer from 2009 to 2013, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007. He joined Abbott in 1987 and became a corporate officer in 2005.

Hubert Allen

Mr. Hubert L. Allen serves as Executive Vice President, General Counsel, Secretary of the Company. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition. He is Elected Corporate Officer in 2012

Mary Moreland

Ms. Mary K. Moreland serves as Executive Vice President of Human Resources of the Company. Prior she serves as Divisional Vice President, Compensation, Benefits and HR M&A.

John Capek

Dr. John M. Capek Ph.D. serves as Executive Vice President - Ventures of the Company. was Executive Vice President - Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Lisa Earnhardt

Ms. Lisa D. Earnhardt serves as Executive Vice President - Medical Devices of the Company. She serves from 2008 to 2019 — President, CEO, and Director, Intersect ENT (a medical technology company focused on developing treatments for ear, nose and throat conditions).

John Ginascol

Mr. John F. Ginascol serves as Executive Vice President - Core Diagnostics of the Company.

Andrew Lane

Mr. Andrew H. Lane serves as Executive Vice President - Established Pharmaceuticals of the Company. From 2014 to 2015 served with Divisional Vice President, Established Pharmaceuticals, Asia Pacific. Between 2011 to 2014 Lane is Vice President, Asia Pacific, Takeda Pharmaceutical Company Limited (a Japanese pharmaceutical company).

Daniel Salvadori

Mr. Daniel Gesua Sive Salvadori serves as Executive Vice President - Nutritional Products of the Company. of the Company. From 2013 to 2014 — Chief Executive Officer, Latin America, CFR Pharmaceuticals S.A. (a Latin American pharmaceutical company). From 2012 to 2013 — Executive President, Complex Therapeutics Division, CFR Pharmaceuticals S.A. From 2010 to 2012 — Head of Sales and Marketing, Latin America, Sandoz Pharmaceuticals, Novartis AG (a Swiss multinational pharmaceutical company). From 2009 to 2010 — Director of Global Strategy and Mergers and Acquisitions, Sandoz Pharmaceuticals, Novartis AG.

Andrea Wainer

Ms. Andrea Wainer serves as Executive Vice President - Rapid and Molecular Diagnostics of the Company. She serves as Vice President, Molecular Diagnostics from 2015 to 2019.

Roger Bird

Mr. Roger M. Bird serves as Senior Vice President - U.S. Nutrition of the Company. Between 2009 to 2015 he is Divisional Vice President and General Manager, China and Hong Kong, Nutritional Products. He is Elected Corporate Officer 2017.

Charles Brynelsen

Mr. Charles R. Brynelsen serves as Senior Vice President - Abbott Vascular of the Company. He serves as Managing Director, CB Business Advisors, Inc. (a medical device consulting firm) from 2016 to 2017. Senior Vice President and President, Medtronic Early Technologies, Medtronic plc (a global medical device company) from 2015 to 2016. President, Early Technologies, Covidien plc (a global healthcare products company) from 2013 to 2015 .

Jaime Contreras

Mr. Jaime Contreras serves as Senior Vice President - Core Laboratory Diagnostics, Commercial Operations of the Company. From 2008 to 2013 he was Vice President, Diagnostics, Global Commercial Operations.

Michael Dale

Mr. Michael Donald Dale serves as Senior Vice President - Structural Heart of the Company. He serves as Vice President, Structural Heart from 2017 to 2019. Divisional Vice President and General Manager, Structural Heart from 2016-2017. President and Chief Executive Officer, GI Dynamics, Inc. (a medical device company focused on developing gastrointestinal therapies) from 2014-2016.

Sammy Karam

Mr. Sammy Karam serves as Senior Vice President - Established Pharmaceuticals, Emerging Markets of the Company. He serve as Divisional Vice President, Global Marketing Commercial Execution, Established Pharmaceuticals from 2014-2019.

Joseph Manning

Mr. Joseph J. Manning serves as Senior Vice President - Nutrition International of the Company. From 2015 to 2017 he was Vice President, Nutrition, Asia Pacific. From 2014 to 2015 he was General Manager, Indonesia, Nutritional Products. From 2009 to 2014 he was General Manager, Russia, Nutritional Products.

Michael Pederson

Mr. Michael J. Pederson serves as Senior Vice President - Electrophysiology and Heart Failure of the Company. Divisional Vice President and General Manager, Abbott Electrophysiology from 2015-2017. Chief Executive Officer, VytronUS, Inc. (a medical device company focused on developing electrophysiology technologies) from 2011-2015.

Christopher Scoggins

Mr. Christopher J. Scoggins serves as Senior Vice President - Rapid Diagnostics of the Company. He serve as Vice President, Diabetes Care, Commercial Operations from 2015-2019. Divisional Vice President, EMEA Commercial Operations, ADC. from 2011-2015.

Jared Watkin

Mr. Jared L. Watkin serves as Senior Vice President - Diabetes Care of the Company. Between 2010 to 2015 Divisional Vice President, Technical Operations, Diabetes Care. Elected as Corporate Officer in 2015.

Alejandro Wellisch

Mr. Alejandro Wellisch serves as Senior Vice President - Established Pharmaceuticals, Latin America of the Company. He serve as General Manager, Argentina, Bolivia, Paraguay and Uruguay, Established Pharmaceuticals.

Randel Woodgrift

Mr. Randel Woodgrift serves as Senior Vice President - CRM of the Company. He serve as Vice President, Global Operations, Cardiovascular and Neuromodulation. Vice President, Operations and R&D, Abbott Vascular.

William Osborn

Mr. William A. (Bill) Osborn serves as Lead Independent Director of the Company. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. As the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company, Mr. Osborn acquired broad experience in successfully overseeing complex global businesses operating in highly regulated industries.

Robert Alpern

Dr. Robert J. Alpern, M.D. , serves as Independent Director of the Company. Dr. Alpern has served as the Ensign Professor of Medicine and Professor of Internal Medicine at Yale School of Medicine since June 2004. From June 2004 to January 2020, Dr. Alpern served as Dean of Yale School of Medicine. From July 1998 to May 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and Tricida, Inc. and served as a Director on the Board of Yale New Haven Hospital from October 2005 through January 2020. As a result of his long-tenured leadership positions at the Yale School of Medicine and The University of Texas Southwestern Medical Center, and as a former Director on the Board of Yale New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Roxanne Austin

Ms. Roxanne S. Austin serves as Independent Director of the Company. Ms. Austin is President and Chief Executive Officer of Austin Investment Advisors, a private investment and consulting firm, and chairs the U.S. Mid-Market Investment Advisory Committee of EQT Partners. Previously, Ms. Austin also served as the President and Chief Executive Officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as President and Chief Operating Officer of DIRECTV, Inc. Ms. Austin also served as Executive Vice President and Chief Financial Officer of Hughes Electronics Corporation and as a partner of Deloitte & Touche LLP. Ms. Austin served on the Board of Directors of Telefonaktiebolaget LM Ericsson from 2008 to 2016. Ms. Austin currently serves on the Board of Directors of AbbVie Inc., CrowdStrike Holdings, Inc., Target Corporation, and Teledyne Technologies, Inc. Ms. Austin will not stand for re-election at Target Corporation's June 2020 annual meeting of shareholders. Through her extensive management and operating roles, including her financial roles, Ms. Austin contributes significant oversight and leadership experience, including financial expertise and knowledge of financial statements, corporate finance and accounting matters.

Sally Blount

Ms. Sally E. Blount, Ph.D., serves as Independent Director of the Company. Ms. Blount is the Michael L. Nemmers Professor of Strategy and former Dean of the J.L. Kellogg Graduate School of Management at Northwestern University from 2010 to 2018. From 2004 to 2010, she served as the Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. Ms. Blount currently serves on the Board of Directors of Ulta Beauty, Inc. and the Joyce Foundation. Having served as Dean of the J.L. Kellogg Graduate School of Management at Northwestern University and as the Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Business, Ms. Blount provides Abbott's Board with expertise on business organization, governance and business management matters.

Michelle Kumbier

Ms. Michelle A. Kumbier serves as Independent Director of the Company. Ms. Kumbier has served as Senior Vice President and Chief Operating Officer of Harley-Davidson Motor Company since October 2017. Previously, she served as its Senior Vice President, Motor Company Product and Operations from May 2015 to October 2017, as its Senior Vice President of Motorcycle Operations from September 2012 to April 2015, and as its Senior Vice President, Product Development from November 2010 to August 2012. As the Senior Vice President and Chief Operating Officer of Harley-Davidson Motor Company, Ms. Kumbier contributes extensive experience in the management of a multinational public company, including significant manufacturing, product development, business development, and strategic planning experience.

Edward Liddy

Mr. Edward M. (Ed) Liddy serves as Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Mr. Liddy has reached the mandatory retirement age for directors at both Boeing and 3M and will not stand for re-election at either company's 2020 Annual Meeting. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reports and accounting matters.

Darren McDew

Mr. Darren W. McDew serves as Independent Director of the Company. From August 2015 to August 2018, General McDew served as Commander, U.S. Transportation Command, the single manager for global air, land and sea transportation for the U.S. Department of Defense. Previously, he also served as Vice Director for Strategic Plans and Policy for the Joint Chiefs of Staff, Military Aide to the President, Director of Air Force Public Affairs, and Chief of Air Force Senate Liaison Division. General McDew currently serves on the Board of Directors of the Boys and Girls Club of America, United Services Automobile Association, and Rolls-Royce, North America, Inc. Through his extensive leadership in the U.S. Air Force, General McDew contributes significant experience managing large, complex global operations, including strategic planning, security and risk management, cybersecurity, and supply chain and infrastructure management.

Nancy McKinstry

Ms. Nancy McKinstry serves as Independent Director of the Company. Ms. McKinstry has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry serves on the Board of Accenture plc, the Board of Overseers of Columbia Business School, and the Board of Directors of Russell Reynolds Associates. Ms. McKinstry is also a member of the European Round Table of Industrialists. Ms. McKinstry served on the Board of Directors of Telefonaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. As the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., Ms. McKinstry contributes global perspectives and management experience, including an understanding of key issues facing a multinational business such as Abbott's.

Phebe Novakovic

Ms. Phebe N. Novakovic serves as Independent Director of the Company. Ms. Novakovic has been Chairman and Chief Executive Officer of General Dynamics Corporation since January 1, 2013. Previously, she served as President and Chief Operating Officer from May 2012 to December 2012 and as Executive Vice President, Marine Systems of General Dynamics from May 2010 to May 2012. From May 2005 to April 2010, Ms. Novakovic served as its Senior Vice President—Planning and Development. She was elected Vice President of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was Special Assistant to the Secretary and Deputy Secretary of Defense, and had been a Deputy Associate Director of the Office of Management and Budget. As a member of the Board of Directors and Chief Executive Officer of General Dynamics Corporation, Ms. Novakovic has strong management experience with a major public company, including significant marketing, operational and manufacturing experience, and contributes valuable insights into finance and capital markets. Her tenure with the Office of Management and Budget and as Special Assistant to the Secretary and Deputy Secretary of Defense enables her to provide government perspective and experience in a highly regulated industry.

Samuel Scott

Mr. Samuel C. Scott III serves as Independent Director of the Company., serves as Independent Director of the Company. Mr. Scott retired as Chairman, President and Chief Executive Officer of Corn Products International in 2009. He served as Chairman, President, and Chief Executive Officer from February 2001 until he retired in May of 2009. He was President and Chief Operating Officer from January 1998 until February 2001. He was President of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the Board of Directors of Bank of New York Mellon Corporation and Motorola Solutions, Inc. As the Chairman, President and Chief Executive Officer of Corn Products International, Mr. Scott acquired valuable business, leadership and management experience, including critical insights into matters relevant to a major public company and experience in finance and capital markets matters.

Daniel Starks

Mr. Daniel J. Starks serves as Independent Director of the Company. Mr. Starks served as the Chairman, President and Chief Executive Officer of St. Jude Medical, Inc. from 2004 until his retirement in January 2016, after which he served as its Executive Chairman of the Board until January 2017, when Abbott completed the acquisition of St. Jude Medical. Mr. Starks also served as President and Chief Operating Officer of St. Jude Medical from 2001 to 2004 and as its President and CEO, Cardiac Rhythm Management Business from 1997 to 2001. Having served as St. Jude Medical's Executive Chairman and its Chairman, President and Chief Executive Officer, and having joined St. Jude Medical in 1996, Mr. Starks contributes not only comprehensive and critical knowledge of St. Jude Medical's operations, but also extensive business and management experience operating a global public company in a highly regulated industry.

John Stratton

Mr. John G. Stratton is Director of the Company. Mr. Stratton served as Executive Vice President and President of Global Operations of Verizon Communications Inc. from February 2015 to December 2018. Previously, he served as Executive Vice President and President of Global Enterprise and Consumer Wireline from April 2014 to February 2015, as President of Verizon Enterprise Solutions from January 2012 to April 2014, and as Chief Operating Officer and Executive Vice President of Verizon Wireless from October 2010 to January 2012. Mr. Stratton currently serves on the Board of Directors of General Dynamics Corporation. Mr. Stratton also served as a member of The President's National Security Telecommunications Advisory Committee from October 2012 to July 2018 and as Director of the Cellular Telecommunications Industry Association from February 2015 to July 2018. Through his executive leadership at Verizon Communications, Mr. Stratton contributes extensive business and management experience operating a global public company such as Abbott, including valuable insights on corporate strategy and risk management. His service on the National Security Telecommunications Advisory Committee enables him to provide government perspective and experience in a highly regulated industry.

Glenn Tilton

Mr. Glenn Fletcher Tilton serves as Independent Director of the Company. Mr. Tilton served as Chairman, President and Chief Executive Officer of UAL Corporation, and Chairman and Chief Executive Officer of United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation, from September 2002 to October 2010. Mr. Tilton also served on the Board of United Continental Holdings, Inc. from 2001 to 2013 and served as its Non-Executive Chairman of the Board from October 2010 to December 2012. Mr. Tilton is also a Director of AbbVie Inc. and Phillips 66. Mr. Tilton also served on the Board of Directors of Lincoln National Corporation from 2002 to 2007, of TXU Corporation from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and as Chairman of the Midwest for JPMorgan Chase & Co. and a member of its companywide Executive Committee from June 2011 to June 2014. Having previously served as Chief Executive Officer of UAL Corporation and United Air Lines, Non Executive Chairman of the Board of United Continental Holdings, Inc., Chairman of the Midwest for JPMorgan Chase & Co., Chairman, President, and Vice Chairman of Chevron Texaco, and as Interim Chairman of Dynegy, Inc., Mr. Tilton acquired strong management experience overseeing complex multinational businesses operating in highly regulated industries, as well as expertise in finance and capital markets matters.